Kala Bio (KALA) FCF Margin (2019 - 2022)
Kala Bio's (KALA) quarterly FCF Margin came in at 3738.81% in Q3 2022, down 287764.0% year-over-year from N/an in Q3 2021, and down 206.81% quarter-over-quarter from 1218.62% in Q2 2022.
Powered by 
Analysis
Kala Bio (KALA) FCF Margin (2019 - 2022) Analysis & Trends
Kala Bio has disclosed FCF Margin across 4 years of filings, most recently posting 3738.81% for Q3 2022.
- In Q3 2022, FCF Margin fell 287764.0% year-over-year to 3738.81%; the TTM figure through Dec 2022 stood at 2035.48% (down 106466.0% YoY), while the FY2022 annual figure was 2035.48%, down 106466.0% from the prior year.
- FCF Margin came in at 3738.81% for Q3 2022 at Kala Bio, down from 1218.62% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 718.91% in Q2 2021 to a low of 3738.81% in Q3 2022.
- Average FCF Margin over 4 years is 1592.59%, with a median of 1504.09% recorded in 2021.
- Year-over-year, FCF Margin surged 166728 bps in 2021 and tumbled 287764 bps in 2022.
- Over 4 years, FCF Margin stood at 1559.32% in 2019, then advanced by 24 bps to 1179.71% in 2020, then retreated by 27 bps to 1504.09% in 2021, then sank by 149 bps to 3738.81% in 2022.
- Per Business Quant data, the three most recent FCF Margin figures were 3738.81% in Q3 2022, 1218.62% in Q2 2022, and 1761.66% in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.55 Bn | 192.56 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 180.15 Bn | 176.98 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 131.59 Bn | 123.73 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 81.98 Bn | 73.98 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.33 Bn | 55.14 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.75 Bn | 48.61 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.06 Bn | 29.76 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.95 Bn | 30.67 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | -18,629.40% |
| 10 | Kala Bio | 8.44 Mn | 8.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -3,738.81% |
| Jun 30, 2022 | -1,218.62% |
| Mar 31, 2022 | -1,761.66% |
| Dec 31, 2021 | -1,504.09% |
| Sep 30, 2021 | -861.17% |
| Jun 30, 2021 | -718.91% |
| Mar 31, 2021 | -1,006.09% |
| Dec 31, 2020 | -1,179.71% |
| Sep 30, 2020 | -1,179.50% |
| Jun 30, 2020 | -2,386.19% |
| Mar 31, 2020 | -1,883.47% |
| Dec 31, 2019 | -1,559.32% |
| Sep 30, 2019 | -1,593.11% |
| Jun 30, 2019 | -1,017.26% |
| Mar 31, 2019 | -2,280.95% |